Jul 16, 2025, 14:47
Bakhos Tannous: Excited to Lead Efforts in an Area Where the Impact Can Be Life-Changing
Bakhos Tannous, Executive Director, Head of Rare Cancer Discovery at AstraZeneca and Alexion Pharmaceuticals, shared a post on LinkedIn:
“I’m happy to share that I’ve started a new position as Executive Director, Head of Rare Cancer Discovery at AstraZeneca and Alexion Pharmaceuticals, Inc.!
I’m incredibly excited to lead efforts across discovery and clinical strategy to bring new therapies for patients with rare cancers—an area where the need is great and the impact can be life-changing.
It’s an honor to join a team so dedicated to advancing science and making a real difference for patients who often have limited treatment options.
Looking forward to what’s ahead!”
More posts featuring AstraZeneca.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 16, 2025, 17:55
Jul 16, 2025, 17:38
Jul 16, 2025, 17:37
Jul 16, 2025, 17:04
Jul 16, 2025, 16:51
Jul 16, 2025, 16:34
Jul 16, 2025, 16:18
Jul 16, 2025, 16:06